| Name: | 21 Dehydro Dexamethasone |
| Catalogue No. | VL273008 |
| CAS No. | 2964-79-6 |
| Molecular Formula | C₂₂H₂₉FO₆ |
| Molecular Weight | 408.46 |
| Status | In-stock |
| IUPAC Name | (11β,16α)-9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-al Hydrate |
| Description | 21 Dehydro Dexamethasone (CAS No: 2964-79-6) or (11β,16α)-9-Fluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-al Hydrate is a 21-dehydro derivative of Dexamethasone which is administered to better the fetal maturation associated with lowered birth weight. It extensively diminishes birth weights after adjustment for a week of gestation. |
| References | Hansen, Jens, and Hans Bundgaard. “Studies on the Stability of Corticosteroids v. the Degradation Pattern of Hydrocortisone in Aqueous Solution.” International Journal of Pharmaceutics, vol. 6, no. 3-4, Sept. 1980, pp. 307–19,https://doi.org/10.1016/0378-5173(80)90114-3.Bloom, S. “Antenatal Dexamethasone and Decreased Birth Weight.” Obstetrics & Gynecology, vol. 97, no. 4, Apr. 2001, pp. 485–90,https://doi.org/10.1016/s0029-7844(00)01206-0. |
![(16α)-21-[(Ethoxycarbonyl)oxy]-17-hydroxy-16-methylpregna-1,4,9(11)-triene-3,20-dione](/public/site/files/site_images/thumb_16alpha-21-ethoxycarbonyl-oxy-17-hydroxy-16-methylpregna-1-4-9-11-triene-3-20-dione47031.png)
